March 5 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* FY TOTAL OPERATING INCOME EUR 37.7 MILLION VERSUS EUR 28.7
MILLION YEAR AGO
* ANNOUNCES 2019 RESULTS AND 2020 OUTLOOK
* ON CORONAVIRUS: IMPACT COVID-19 OUTBREAK: GUIDANCE FOR
2020
ASSUMES A MODERATE IMPACT OF ONGOING WORLDWIDE COVID-19 OUTBREAK
* TARGETED CASH POSITION IN RANGE OF EUR 110M BY 2020 YEAR
END
* SEES 2020 COMMERCIAL CARTRIDGE VOLUME: TARGETING A
YEAR-OVER-YEAR COMMERCIAL VOLUME GROWTH IN RANGE OF 30%
* SEES 2020 INSTALLED BASE: TARGETING AN INSTALLED BASE
GROWTH IN
RANGE OF 300-350 NEW INSTRUMENT PLACEMENTS.
* FY NET LOSS EUR 64.1 MILLION VERSUS LOSS OF EUR 48.2
MILLION
YEAR AGO
* CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 179M AS PER 31
DECEMBER 2019
* FY TOTAL PRODUCT SALES INCREASED YEAR-OVER-YEAR WITH 29%
TO EUR
24.2M IN 2019 (EUR 18.8M IN 2018)
Source text for Eikon: ID:nGNEb6Nrs4
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))